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Abstract
Stable isotope tracer methodologies are becoming increasingly widespread in
metabolic research; yet a number of factors restrict their implementation, such
as, i.v infusions, multiple cannulae, tissue samples, and significant cost. We
recently validated the sensitivity of the orally administered stable isotope
tracer deuterium oxide (D2O) for quantifying day-to-day changes in muscle
protein synthesis (MPS). This method is less invasive, restrictive, and more
cost-effective than traditional amino acid (AA) tracer techniques. In the
present study, we hypothesized the sensitivity of our analytical techniques
(GC-Pyrolysis-IRMS) would permit D2O-derived measurements of MPS over
much shorter periods (i.e., hours) usually only possible using AA-tracer tech-
niques. We recruited nine males (24  3 year, BMI: 25  3 kgm²) into an
internally controlled comparison of D2O versus
13C AA-tracers. The day
before the acute study subjects consumed 400 mL D2O, and on the study day,
received a primed (0.3 mgkg1) continuous (0.6 mgkgh1) i.v infusion of
L-[ring-13C6]-phenylalanine to quantify MPS under both: (1) basal [postab-
sorptive] and; (2) stimulated [postprandial] that is, consumption of 20 g
EAA, conditions. Measures of MPS yielded indistinguishable technique differ-
ences with respect to EAA, 13C: 0.065  0.004 to 0.089  0.006%h1
(P < 0.05) and D2O: 0.050  0.007 to 0.088  0.008%h1 (P < 0.05) with
qualitatively similar increases. Our findings reveal that acute measurement of
MPS, usually only possible using AA-tracers, are feasible over shorter periods
with orally administered D2O when used in tandem with GC-Pyrolysis-IRMS.
We conclude that this D2O approach provides a less invasive, cost-effective,
and flexible means by which to quantify MPS acutely over several hours.
Introduction
Stable isotope tracers have been at the forefront of
metabolic research since the successful isolation of the
stable isotope deuterium by Harold Urey in 1931 (Urey
et al. 1932). This combined with the rapid and dedicated
development of these new techniques over subsequent
years by Urey, Schoenheimer, and Rittenberg, has
provided us with an exquisite array of tools for
understanding metabolic systems and substrate turnover
(Schoenheimer and Rittenberg 1935, 1938; Rittenberg and
Schoenheimer 1937; Rennie et al. 1982; Zhang et al. 1996,
2012; Wolfe and Chinkes 2005). Such isotopic methodol-
ogies have been key to our understanding of the regula-
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tion of skeletal muscle mass in particular (Atherton and
Smith 2012). With the diversity of muscle functions rang-
ing from; the control of locomotion and physical function
to acting as a fuel reservoir for other organs in times of
stress/illness, maintenance of muscle mass is essential for
ensuring metabolic health, in addition to maintaining
independence and quality-of-life into older age.
Over recent decades, the study of human muscle pro-
tein turnover has been aided through the use of stable
isotopically labeled amino acids (AA) with either heavy
carbon (13C), hydrogen (2H) or nitrogen (15N) motifs.
The incorporation of these labeled AA into muscle pro-
tein permits the calculation of a fractional synthetic rate
(FSR) of muscle protein synthesis (MPS). Whilst moni-
toring of the rate of disappearance of the tracer from the
arterial pool, and appearance of the tracer in the venous
pool across a specified tissue provides rates of synthesis
and breakdown respectively. However, these approaches
have limitations. Application of these tracers often
requires complex experimental set-up involving i.v infu-
sions, which necessitate venous (and arterial) cannulation,
alongside multiple biopsies and are generally restricted to
periods of up to 12 h. Such limitations make it difficult
to apply these techniques to certain populations (frail
elderly, critical care, CKD, young children and adoles-
cents) and also restrict the acquisition of longer term,
potentially more habitually relevant metabolic readouts.
We have recently demonstrated that by providing a sin-
gle oral bolus of the tracer deuterium oxide (D2O), we
were able to accurately measure MPS over a period of as
little as 2 days both at rest and in response to exercise
(Wilkinson et al. 2014). This method is far less invasive,
requiring only a single tissue [muscle] biopsy, and has
been used to measure MPS over periods between 1 or
2 days (Gasier et al. 2012; Wilkinson et al. 2014)) to sev-
eral weeks (Robinson et al. 2011). Due to the sensitivity
of the methods we pioneered, that is, GC-pyrolysis-IRMS,
we predicted we would be able to detect MPS differences
over even shorter periods of several hours (~3–6 h), a
time period generally only conducive to the use of tradi-
tional AA-tracers. If true, this would provide an alterna-
tive for the measurement of MPS without the need for
invasive routes of tracer administration or multiple-blood
and tissue sampling in a more cost-effective and less inva-
sive manner. As such, the aim of this study was to inter-
nally compare our D2O tracer technique against
traditional AA-tracer techniques using L-[ring-13C6] phen-
ylalanine; we quantified MPS using both tracers under
basal (postabsorptive) and stimulated (postprandial) con-
ditions. A comparison between phenylalanine tracers and
D2O for the measurement of acute MPS has been per-
formed previously (Gasier et al. 2009), however, rats
turnover approximately 10-fold faster than humans, addi-
tionally there were distinct differences between measure-
ment periods employed (4 h and 24 h for D2O and 12
mins for Phenylalanine) and mode of tracer administra-
tion (phenylalanine was administered as a flooding dose
rather than primed constant infusion). In the present
study, we performed an internal comparison in humans
between L-[ring-13C6] phenylalanine and D2O within the
same individuals using the same design and measurement
periods, in order to determine whether D2O could pro-
vide a robust alternative, and simpler, less burdensome
approach for use in laboratories and populations where
repeat invasive sampling and i.v tracer administration
may not be possible.
Materials and Methods
Subject characteristics and ethics
Nine healthy youngmales (24  3 year, BMI: 25  3 kgm²)
were recruited. All subjects were screened by means of a
medical questionnaire, physical examination, and resting
ECG, with exclusions for metabolic, respiratory, and car-
diovascular disorders or other symptoms of ill-health.
Subjects had normal blood chemistry, were normotensive
(BP < 140/90) and were not prescribed any medications;
all subjects performed activities of daily living and recre-
ation. All subjects gave their written, informed consent
to participate after all procedures and risks were
explained. This study was approved by The University of
Nottingham Ethics Committee and complied with the
Declaration of Helsinki.
Study procedures
Subjects were asked to refrain from heavy exercise for
72 h before the start of the study. About 24 h prior to
the start of the study, following provision of a basal saliva
sample, each subject was provided with 400 mL D2O (70
Atom%, Sigma Aldrich, Poole, UK), which was consumed
in four doses of 100 mL at 2 h intervals from 2 pm that
afternoon (to avoid potential side effects associated with
consumption of large doses of D2O, e.g., dizziness, nau-
sea). The subjects were advised to consume their normal
diet that evening and following an overnight fast (>10 h),
subjects arrived to the laboratory at ~0830 h the following
day and had an 18 g cannula inserted into the antecubital
vein of one arm for tracer infusion and a retrograde 14 g
cannula inserted to sample arterialized blood from the
dorsal capillary bed of the opposite hand (using the ‘hot
hand’ method; (Greenhaff et al. 2008)). A primed, contin-
uous infusion (0.3 mgkg1 prime, 0.6 mgkgh1 contin-
uous infusion) of L-[ring-13C6]-phenylalanine (99 Atoms
%, Cambridge Isotopes Limited, Cambridge, MA) was
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started (at t = 1 h) and maintained until the end of the
study (6 h). 1 h after the beginning of the infusion the
first biopsy was collected (0 h) with a second biopsy col-
lected 3 h later (3 h). This allowed us to gather “basal”,
postabsorptive measurements (0–3 h), before subjects
consumed 20 g of essential amino acids (EAA; see Table 1
for composition, with 6% of the phenylalanine provided
as L-[ring-13C6]-phenylalanine to prevent dilution of the
tracer) dissolved in 250 mL of water for measures of
postprandial MPS from 3–6 h, with the third and final
biopsy collected at 6 h. Muscle biopsies (~200 mg) were
taken from m. vastus lateralis under sterile conditions
using local anesthetic (1% lidocaine). A schematic of the
protocol is shown in Fig. 1. In addition to blood and
muscle, subjects provided saliva throughout (inclusive of
a sample prior to oral administration of D2O) for the
measurement of body water enrichment.
Body water enrichment
Water was obtained from saliva samples prior to analysis.
100 lL aliquots of saliva were placed in the cap of
inverted auto-sampler vials; these were then placed on a
heating block at 90°C for 4 h. Water distillate was col-
lected by rapidly cooling the vials on ice for 10 min, and
was transferred to fresh vials for direct liquid injection
into a high temperature conversion elemental analyzer
(TC/EA; Thermo Scientific, Hemel Hempstead, UK) con-
nected to an Isotope Ratio Mass Spectrometer (IRMS,
Delta V Advantage; Thermo Scientific) as previously
described Wilkinson et al. (2014).
Isolation and derivatization of myofibrillar
protein fractions
For isolation of myofibrillar fractions ~30–50 mg of
muscle was used. The muscle was homogenized in ice-
cold homogenization buffer (50 mmolL1 Tris-HCl (pH
7.4), 50 mmolL1 NaF, 10 mmolL1 b-Glycerophos-
phate disodium salt, 1 mmolL1 EDTA, 1 mmolL1
EGTA, 1 mmolL1 activated Na3VO4 (all Sigma-
Aldrich)) and a complete protease inhibitor cocktail tab-
let (Roche, West Sussex, UK) at 10 lLlg1 of tissue.
Homogenates were rotated for 10 min and the superna-
tant collected by centrifugation at 10,000 9 g for 5 min
at 4°C. The myofibrillar pellets were solubilized in
0.3 molL1 NaOH, separated from insoluble collagen by
centrifugation and the myofibrillar protein precipitated
with 1 molL1 perchloric acid (PCA). Protein-bound AA
were released using acid hydrolysis by incubating in
0.1 molL1 HCl in Dowex H+ resin slurry overnight at
110°C before being eluted from the resin with 2 molL1
NH4OH and evaporated to dryness. The AA were then
derivatized as their n-methoxycarbonyl methyl esters
(MCME) according to the protocol of Husek (Husek
and Liebich 1994) with slight modifications. The dried
samples were resuspended in 60 lL of distilled water
and 32 lL of methanol, following a brief vortex, 10 lL
of pyridine and 8 lL of methylchloroformate were
added. Samples were vortexed for 30 sec and left to
react at room temperature for 5 min. Newly formed
MCME AA were then extracted into 100 lL of chloro-
Table 1. Composition of essential amino acid drink.
Essential
amino acid
Mass
added (g)
Percentage mass added
(%)
Histidine 1.61 8.09
Isoleucine 2.31 11.60
Leucine 4.79 24.06
Lysine 4.09 20.54
Methionine 1.27 6.38
Phenylalanine 1.21 6.08
Threonine 1.51 7.58
Tryptophan 0.64 3.21
Valine 2.48 12.46
Figure 1. Schematic of D2O L-[ring-
13C6]-Phenylalanine dual tracer comparison study protocol.
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form; any remaining water was removed from the sam-
ple with addition of a molecular sieve. Incorporation of
deuterium into protein-bound alanine was determined
by gas chromatography-pyrolysis-isotope ratio mass
spectrometry, and the incorporation of L-[ring-13C6]
phenylalanine into myofibrillar protein by gas chroma-
tography-combustion-isotope ratio mass spectrometry.
Both analyses were performed using the same system
(Delta V Advantage; Thermo Scientific) utilizing a GC
isolink and four port switching-valve to permit switching
between pyrolysis and combustion ovens.
Plasma/intracellular phenylalanine labeling
and plasma BCAA concentrations
For plasma AA concentration and enrichment measure-
ments, proteins were precipitated with 100% ethanol fol-
lowing addition of 10 lL of norleucine internal standard
(250 lgmL1) and the supernatant evaporated to dry-
ness, reconstituted in 0.5 molL1 HCl and the lipid frac-
tion removed using ethyl acetate extraction. The
remaining aqueous phase was then evaporated to dry-
ness. For intracellular enrichment, 200 lL of the sarco-
plasmic fraction was deproteinized with 1 molL1 PCA,
the supernatant was neutralized and purified on Dowex
H+ resin before being evaporated to dryness. Plasma and
intracellular phenylalanine, and plasma leucine, isoleu-
cine and valine were then converted to their tBDMS
derivative and enrichment (APE) determined using gas
chromatography-mass spectrometry (Trace 1300 - ISQ,
GC-MS and Trace 1310 – TSQ, GC-MS/MS; Thermo
Scientific) in single ion monitoring mode. Plasma BCAA
concentrations were determined with reference to a stan-
dard curve.
Calculation of fractional synthetic rate (FSR)
The FSR of myofibrillar proteins (MPS) using the D2O
tracer was determined, using the precursor-product
approach, from the incorporation of deuterium labeled
alanine into protein, using the enrichment of body water
(corrected for the mean number of deuterium moieties
incorporated per alanine, 3.7, and the total number of
hydrogen within the alanine derivative, 11) as the surro-
gate precursor labeling between subsequent biopsies. In
brief, the standard equation is:
FSR ð%  h1Þ ¼ ½ðdAlaÞ½ðdPÞ  t  100
where, dAla = deuterium enrichment (in delta excess) of
protein-bound alanine between subsequent biopsies,
dP = precursor enrichment (in delta excess) and t, time
between biopsies.
Fractional synthetic rate (FSR) of myofibrillar proteins
using the L-[ring-13C6]-phenylalanine tracer was calcu-
lated using the same standard precursor-product equation
as above:
FSR ð%  h1Þ ¼ ½ðEmÞ½ðEpÞ  t  100
where Em = the change in the protein bound L-
[ring-13C6]-phenylalanine enrichment in atoms per excess
(APE) between subsequent biopsies and Ep = the mean
enrichment over the same time period (t) of the precur-
sor for protein synthesis (calculated from the mean of the
two intracellular L-[ring-13C6]-phenylalanine enrichment
(APE) over the defined measurement period).
Statistical analyses
Descriptive statistics were produced for all data sets to
check for normal distribution (accepted if P > 0.05) using
a Kolmogorov–Smirnov test. Differences within groups
and between groups (feed 9 tracer) were detected by
two-way ANOVA with a Sidak-Holm post hoc test using
GraphPad Prism software (Version 5, La Jolla, San Diego
CA). Limits of agreement between methods were per-
formed using Bland–Altman plots, with correlations ana-
lyzed using Pearson’s Product Moment coefficient. The
alpha level of significance was set at P < 0.05. All data are
presented as mean  SEM.
Results
Plasma AA concentrations
As would be expected, we observed significant increases
in plasma AA concentrations following EAA consumption
as represented by the concentrations of leucine, valine,
and isoleucine (P < 0.01; Fig. 2). Concentrations of AA
peaked ~60 min following feeding and were significantly
different from fasted at all postprandial time points dur-
ing the study period.
Body water, plasma, and intracellular
phenylalanine enrichment
Body water enrichments were ~33,000 d and due to the
slow turnover rate of body water this level of enrichment
maintained a pseudo-steady state throughout the acute
study period (see Fig. 3). Plasma L-[ring-13C6] phenylala-
nine enrichment also maintained a steady state through-
out the study period. Mean intracellular L-[ring-13C6]
phenylalanine enrichment for the postabsorptive and
postprandial periods were 4.1  0.5 and 4.75  0.2 APE
respectively.
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Myofibrillar protein synthesis: comparison
of D2O and L-[ring-
13C6]-phenylalanine
tracers
Postabsorptive rates of MPS were 0.050  0.007 and
0.065  0.004%h1, respectively, using the D2O and
L-[ring-13C6]-phenylalanine tracers (Fig. 4A). Following
consumption of the EAA solution, rates of MPS
increased to 0.088  0.008 and 0.089  0.006%h1
respectively, this was significantly higher than postabsorp-
tive rates for each tracer (Fig. 4A). Despite the qualita-
tively similar means-based data, if each subject is
investigated individually and the two tracer techniques
are directly compared quantitatively, the rates produced
from the two techniques did not always yield the same
differences (Fig. 4B and C). A Bland–Altman plot of the
agreement between the two methods can be observed in
Fig. 5A, with the calculated bias between the two meth-
ods 0.0083, suggesting that overall the two methods agree
reasonably well, however, it can be observed from the
plot that a small number of data points do not agree so
well with one falling outside the 95% confidence inter-
vals. Despite this, there was a significant correlation
between FSR for the two methods; Pearson r = 0.438,
one tailed P = 0.035, two tailed P = 0.069 (Fig. 5B), as
well as the delta FSR change from postabsorptive to post-
prandial (Fig. 5C).
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Figure 2. Plasma (A) Leucine (B) Isoleucine, and (C) Valine
concentrations. *Significantly different from fasted P < 0.05.
A
B
Figure 3. (A) Saliva body water enrichment in delta excess
notation and (B) plasma phenylalanine enrichment in APE.
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Discussion
The requirement for complex clinical experimental set-up,
alongside the need for invasive cannulation and biopsy
techniques limits the application of acute AA-tracer tech-
niques; especially within certain populations. Here, we
show that it is possible to quantify MPS over several
hours without the need for cannulation or the iv infusion
of expensive AA-tracers. Using an oral dose of D2O, we
demonstrate that with collection of saliva and muscle
samples it is possible to accurately quantify MPS over as
short a period as 3 h in the postabsorptive state, whilst
also being able to detect significant increases in MPS in
the postprandial state. Furthermore, this technique pro-
duced comparable mean rates to that obtained when
using traditional L-[ring-13C6]-phenylalanine tracers in
the same individuals (see Fig. 4A).
Despite being the first stable isotope tracer to be used
by the pioneers of the technique Schonheimer and Ritten-
berg in the 1930s (Schoenheimer and Rittenberg 1935,
1938; Rittenberg and Schoenheimer 1937), D2O has been
largely overlooked in favor of metabolite-specific stable or
radio-labeled tracers until the last decade when its rein-
troduction has garnered great interest (Dufner and Previs
2003; Gasier et al. 2010; Robinson et al. 2011; Wilkinson
et al. 2014). Indeed D2O is advantageous for a number of
reasons including the possibility to quantify turnover of
multiple substrate pools; indeed, our laboratory, as well
A
D
B C
Figure 4. (A) Comparison of mean postabsorptive (PA) and postprandial (PP) myofibrillar FSR as measured using D2O (black bars) and L-
[ring-13C6]-phenylalanine (clear bars). *P < 0.05; ***P < 0.001. (B) Individual carbon FSR values, and (C) Individual D2O FSR values. (D) Absolute
d excess values for carbon and deuterium tracers.
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as others have shown its novel utility for measuring the
turnover of protein (Robinson et al. 2011; Wilkinson
et al. 2014), lipids (Strawford et al. 2004), DNA (Busch
et al. 2008) and glucose (Katanik et al. 2003) amongst
others. By taking advantage of the relatively slow turnover
rate of the body water pool (half-life ~11 days (Mac-
Donald et al. 2013; Wilkinson et al. 2014)) this also per-
mits long-term measurements that are not possible with
other techniques. For example, in a recent study (Wilkin-
son et al. 2014) we demonstrated the potential D2O has
to detect changes in MPS over 2–8 days when using our
highly sensitive analytical techniques, further to this its
utility for measuring MPS over longer periods has also
been highlighted (Robinson et al. 2011; Miller et al.
2013), with additional studies providing validation of this
technique for MPS and plasma protein turnover measures
(Belloto et al. 2007; Gasier et al. 2009). In the present
study, we have taken this a step further. Herein, we show
that in providing a single-dose of D2O, we are able to
acutely quantify MPS over periods of ~3 h— equivalent
to what is possible with traditional AA-tracers (see
Fig. 4A). Moreover, using our sensitive techniques we
show that D2O-derived FSR values yield rates of MPS that
are extremely well aligned to those using traditional AA-
tracer techniques in this and past studies (Mitchell et al.
2014; Phillips et al. 2014), which for myofibrillar FSR
range between 0.02 and 0.07%h1 (Kumar et al. 2009;
Smith et al. 2011). This engenders confidence we are
accurately measuring quantitative readouts of MPS;
indeed, previous studies using the D2O tracer technique
from other groups have yielded absolute rates of MPS far
out-with normal ranges (8–10%day1; equivalent to
~0.3–0.4%h1; (Gasier et al. 2012; Lambert et al. 2015)),
when measuring using far less sensitive equipment to that
in the present study (GC-MS compared to GC-IRMS),
therefore providing doubts as to robustness of this previ-
ous data.
Proof-of-concept that the application of these D2O
tracers is feasible over shorter periods also requires exam-
ination of the capacity to distinguish changes in response
to anabolic or for that matter, catabolic stimuli. To deter-
mine this, we elected to provide an oral bolus of EAA
since these are known to be the nutritional components
responsible for postprandial stimulation of tissue synthesis
(in this case, MPS). We showed that the associated
plasma aminoacidemia led to an expected increase in
MPS using both tracers (statistically different from base-
line in comparison to tracer-respective postabsorptive val-
ues), and also that there were no means-based differences
between the tracers either under postabsorptive or post-
prandial conditions. Therefore, our results reveal that the
techniques we applied are robust not only in the context
of accurate quantitation of MPS but also in response to a
well-defined anabolic stimuli. Collectively, these findings
demonstrate the potential for D2O to replace AA-tracers
from the perspective of: (1) studying vulnerable popula-
tions (frail elderly, adolescent, clinical populations etc.);
(2) reducing study invasiveness; (3) reducing clinical
inputs; and (4) reducing study costs.
Whilst there are obvious benefits to this technique, we
would also like to acknowledge some potential limita-
tions. Using means-based analysis, both the use of D2O
and L-[ring-13C6]-phenylalanine techniques produce simi-
lar rates of MPS, with a similar increase in MPS with a
20 g EAA bolus (~+0.02–0.03%h1; see Fig. 4A). Despite
the same qualitative change, on an individual basis the
two techniques did not quantitatively agree in all subjects
in terms of absolutes rates (see Fig. 4B and C). Despite
these quantitative differences, Bland–Altman plots
revealed a relatively low bias between the two methods of
A
B
C
Figure 5. (A) Bland–Altman plot of comparison between the two
tracer methods, (B) Correlation between FSR values produced using
each tracer method, (C) Correlation between the change in FSR
due to anabolic stimulus (EAA feed).
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0.0083, which suggests that overall there were minimal
differences between the methods; furthermore there was a
significant correlation between the two (Fig. 5B). A simi-
lar finding was also observed previously when D2O was
compared with a phenylalanine tracer in a rat model (Ga-
sier et al. 2009); here the authors explained that the
quantitative difference may have been due to the differ-
ences in measurement periods and methodologies
between the phenylalanine and D2O techniques (12 min
and 4 h respectively), and the methodologies used for tra-
cer administration. Furthermore, Belloto et al. (2007)
compared D2O with radiolabeled leucine tracers for the
measurement of plasma apoB100-VDL protein turnover,
highlighting overall qualitatively comparable rates of turn-
over using the two methods similar to the present find-
ings. In the present study, we believe that the discrepancy
in the absolute rates may be due to analytical precision.
Measurement precision for analysis of hydrogen using
Pyrolysis-IRMS is ~1–2 delta in our hands on the pres-
ently used equipment (Delta V Advantage, Thermo Scien-
tific) whilst carbon measurement precision via
Combustion-IRMS is ~10 times greater than hydrogen at
between 0.1 and 0.3 delta. Therefore, with such small
delta shifts over 3 h for hydrogen, the measurement accu-
racy of this technique may affect the quantitative accuracy
of the calculated rates somewhat. To combat this, one
could increase the dosage of D2O to an appropriate level
so that this measurement error is reduced, although this
could introduce greater risk of adverse reaction (nausea,
dizziness) in the individuals being tested, however, this
could be avoided with provision of small regular doses
over several hours. It should also be noted that there is
no definitive methodology for performing such tracer val-
idation studies, as each approach studied here comes with
its own set of limitations and assumptions associated with
the tracer and the calculations, but given this it is reassur-
ing that there is a strong level of agreement between the
two approaches.
In conclusion, here we show that D2O can act as an
effective alternative to traditional AA-tracers when mea-
suring MPS acutely. It only requires oral dosing of D2O
24 h prior to the measurement period, regular saliva
samples, and appropriately positioned biopsy sampling.
This reduces the need for additional invasive sampling
and significantly reduces overall study costs, and subject
burden, permitting measurement of MPS in clinical situ-
ations or study populations where it previously was not
possible.
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